RENB

0.4701

10.29% -0.0539

After Hours: .48 0.0099 +2.11%

Renovaro Inc (RENB)

Overview News Price History Option Chain Discussions Forecast

Renovaro Inc stock is traded at $0.4701, with a volume of 614.74K. It is down -10.29% in the last 24 hours and down -47.40% over the past month.

Previous Close:

$0.524

Open:

$0.5

24h Volume:

614.74K

Relative Volume:

0.47

Market Cap:

$76.34M

Revenue:

Net Income/Loss:

$-41.23M

P/E Ratio:

-0.6716

EPS:

-0.7

Net Cash Flow:

$-11.54M

1W Performance:

-27.62%

1M Performance:

-47.40%

6M Performance:

-6.37%

1Y Performance:

-83.03%

1-Day Range:

$0.4619

$0.52

1-Week Range:

$0.4619

$0.635

52-Week Range:

$0.395

$2.97

Renovaro Inc Stock (RENB) Company Profile

Name

Renovaro Inc

Sector

Healthcare (1182)

Industry

Biotechnology (678)

Phone

45 39179840

Address

CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES

Employee

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

RENB's Discussions on Twitter

Compare RENB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RENB Renovaro Inc	0.4701	76.34M	0	-41.23M	-11.54M	-0.70
VRTX Vertex Pharmaceuticals Inc	484.01	124.29B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	610.64	68.39B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	590.06	35.99B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	262.16	33.93B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	264.32	28.47B	3.81B	-644.79M	-669.77M	-6.24

Renovaro Inc Stock (RENB) Latest News

Apr 02, 2025

Charles Schwab Investment Management Inc. Buys 163,160 Shares of Renovaro Inc. (NASDAQ:RENB) - Defense World

Apr 02, 2025

Apr 01, 2025

Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Apr 01, 2025

Predictive Oncology pushing forward with Renovaro merger despite $10.8M loss in 2024 - The Business Journals

Apr 01, 2025

Predictive Oncology Advances AI Merger Plans Despite $10.8M Loss: Key Strategic Moves Revealed - Stock Titan

Apr 01, 2025

Mar 30, 2025

Bank of New York Mellon Corp Grows Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World

Mar 30, 2025

Mar 21, 2025

PawTides.com Partners with Rescue 22 Foundation to Support Veterans and Rescue Dogs - openPR

Mar 21, 2025

Mar 11, 2025

Rhumbline Advisers Acquires 62,204 Shares of Renovaro Inc. (NASDAQ:RENB) - Defense World

Mar 11, 2025

Mar 07, 2025

New York State Common Retirement Fund Trims Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World

Mar 07, 2025

Mar 04, 2025

Predictive Oncology receives financing from Renovaro Biosciences - Pennsylvania Business Report -

Mar 04, 2025

Renovaro (RENB) and Predictive Oncology Partner for AI-Driven Drug Discovery: What’s Next for Cancer and HIV Treatments? - Yahoo Finance

Mar 04, 2025

Mar 03, 2025

Sea (SE) Reports Q4: Everything You Need To Know Ahead Of Earnings - The Globe and Mail

Mar 03, 2025

Renovaro provides financing to Predictive Oncology as both move to finalize definitive merger agreement - The Business Journals

Mar 03, 2025

MarketsMedicine Hat News - Financial Content

Mar 03, 2025

Milestone Merger Payment made with Predictive Oncology to Advance AI-Driven Biomarker Discovery and Precision Medicine in Cancer and Beyond: Renovaro, Inc. (NASDAQ: RENB) - The Globe and Mail

Mar 03, 2025

What To Expect From Best Buy’s (BBY) Q4 Earnings - The Globe and Mail

Mar 03, 2025

Milestone Merger Payment made with Predictive Oncology - openPR

Mar 03, 2025

Renovaro Completes First Milestone Payment To Finalize Definitive Agreement With Predictive Oncology - Marketscreener.com

Mar 03, 2025

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology - GlobeNewswire

Mar 03, 2025

Predictive Oncology Moves To Finalize Definitive Merger Agreement With Renovaro Biosciences - Marketscreener.com

Mar 03, 2025

Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences - The Manila Times

Mar 03, 2025

Renovaro Biosciences Advances Financing for AI-Driven Integration and Strategic Expansion in Oncology through Acquisition of Predictive Oncology - Nasdaq

Mar 03, 2025

Can Renovaro's AI Oncology Merger Unlock Value From 150,000+ Tumor Samples? - StockTitan

Mar 03, 2025

Can This AI-Powered Oncology Merger Transform Cancer Treatment? First Financing Milestone Reached - StockTitan

Mar 03, 2025

Feb 28, 2025

Renovaro Stock Price, Quotes and Forecasts | NASDAQ:RENB - Benzinga

Feb 28, 2025

Renovaro Biosciences Announces Merger with BioSymetrics - TipRanks

Feb 28, 2025

Rocket Lab Stock Is Down 30% in the Last Month. Should You Buy the Dip or Run Far Away? - The Globe and Mail

Feb 28, 2025

Renovaro announces $15 million in equity - MSN

Feb 28, 2025

Feb 27, 2025